**Question:** The investigation of choice for extra-adrenal pheochromocytoma

A. Computed Tomography (CT) scan
B. Magnetic Resonance Imaging (MRI)
C. Urinary VMA (Vanillylmandelic Acid) test
D. Chromogranin A

**Core Concept:**
Pheochromocytoma is a tumor of chromaffin cells in the adrenal medulla, which are responsible for producing catecholamines (epinephrine, norepinephrine, and dopamine). Extra-adrenal pheochromocytoma occurs outside the adrenal glands, including tumors in the sympathetic ganglia, pancreas, and paraganglia. These tumors secrete catecholamines and cause catecholamine-related symptoms, such as hypertension, palpitations, sweating, and headaches.

**Why the Correct Answer is Right:**

1. Computed Tomography (CT) scan: CT scans are a valuable tool for imaging extra-adrenal pheochromocytomas, as they can visualize soft tissue and vascular structures. They can delineate the tumor size, location, and relationship to surrounding structures.

2. Magnetic Resonance Imaging (MRI): MRI is another effective modality for imaging extra-adrenal pheochromocytomas, particularly for detecting lesions in the head and neck, brain, and spinal cord regions. MRI is particularly useful for distinguishing between pheochromocytomas and paragangliomas, which are both catecholamine-secreting tumors but have different MRI characteristics.

**Why Each Wrong Option is Incorrect:**

3. Urinary VMA (Vanillylmandelic Acid) test: The VMA test is primarily used to diagnose pheochromocytoma and paraganglioma by measuring the urinary excretion of VMA, normetanephrine, and metanephrine levels. While the test can provide valuable information, it is not the most reliable investigation for detecting extra-adrenal pheochromocytomas, as the test may be influenced by factors like diet, exercise, and medications.

4. Chromogranin A (CgA): Chromogranin A is a glycoprotein released from endocrine tumors, including pheochromocytomas and paragangliomas. However, Chromogranin A is not specific to these tumors and may be elevated in various other conditions like gastrinomas, insulinomas, and pancreatic neuroendocrine tumors. Therefore, Chromogranin A is not a reliable marker for extra-adrenal pheochromocytoma diagnosis.

**Clinical Pearls:**

1. Pheochromocytomas and paragangliomas are often associated with genetic syndromes like multiple endocrine neoplasia type 2 (MEN2), von Hippel-Lindau disease, and neurofibromatosis type 1 (NF1). These genetic disorders can lead to extra-adrenal pheochromocytomas and should be considered in the differential diagnosis.

2. In cases where imaging studies are